Literature DB >> 32609646

Five genetic polymorphisms of cytochrome P450 enzymes in the Czech non-Roma and Czech Roma population samples.

Lucie Dlouhá1,2, Věra Adámková3, Lenka Šedová4, Věra Olišarová4, Jaroslav A Hubáček1, Valérie Tóthová4.   

Abstract

Objectives Cytochromes P450 play a role in human drugs metabolic pathways and their genes are among the most variable in humans. The aim of this study was to analyze genotype frequencies of five common polymorphisms of cytochromes P450 in Roma/Gypsy and Czech (non-Roma) population samples with Czech origin. Methods Roma/Gypsy (n=302) and Czech subjects (n=298) were genotyped for CYP1A2 (rs762551), CYP2A6 (rs4105144), CYP2B6 (rs3745274) and CYP2D6 (rs3892097; rs1065852) polymorphisms using PCR-RFLP or Taqman assay. Results We found significant allelic/genotype differences between ethnics in three genes. For rs3745274 polymorphism, there was increased frequency of T allele carriers in Roma in comparison with Czech population (53.1 vs. 43.7%; p=0.02). For rs4105144 (CYP2A6) there was higher frequency of T allele carriers in Roma in comparison with Czech population (68.7 vs. 49.8%; p<0.0001). For rs3892097 (CYP2D6) there was more carriers of the A allele between Roma in comparison with Czech population (39.2 vs. 38.2%; p=0.048). Genotype/allelic frequencies of CYP2D6 (rs1065852) and CYP1A2 (rs762551) variants did not significantly differ between the ethnics. Conclusions There were significant differences in allelic/genotype frequencies of some, but not all cytochromes P450 polymorphisms between the Czech Roma/Gypsies and Czech non-Roma subjects.

Entities:  

Keywords:  Czech majority; Roma/Gypsy; cytochromes P450; polymorphism

Year:  2020        PMID: 32609646     DOI: 10.1515/dmdi-2020-0103

Source DB:  PubMed          Journal:  Drug Metab Pers Ther        ISSN: 2363-8915


  2 in total

1.  Different prevalence of T2DM risk alleles in Roma population in comparison with the majority Czech population.

Authors:  Jaroslav A Hubáček; Lenka Šedová; Věra Olišarová; Věra Adámková; Valérie Tóthová
Journal:  Mol Genet Genomic Med       Date:  2020-06-24       Impact factor: 2.183

2.  Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population.

Authors:  Chunjuan He; Linna Peng; Shishi Xing; Dandan Li; Li Wang; Tianbo Jin
Journal:  Pharmgenomics Pers Med       Date:  2021-08-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.